43 ms·
An earlier paper, "Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus Infection", Cell, May 2021, https://papers.ssrn.com/sol3/papers.cfm?
by walterbell 5y ago
An earlier paper, "Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus Infection", Cell, May 2021, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3838993 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3838993
> .. our analysis revealed significant qualitative differences between the two types of immune challenges. In COVID-19 patients, immune responses were characterized by a highly augmented interferon response which was largely absent in vaccine recipients. Increased interferon signaling likely contributed to the observed dramatic upregulation of cytotoxic genes in the peripheral T cells and innate-like lymphocytes in patients but not in immunized subjects. Analysis of B and T cell receptor repertoires revealed that while the majority of clonal B and T cells in COVID-19 patients were effector cells, in vaccine recipients clonally expanded cells were primarily circulating memory cells. Importantly, the divergence in immune subsets engaged, the transcriptional differences in key immune populations, and the differences in maturation of adaptive immune cells revealed by our analysis have far-ranging implications for immunity to this novel pathogen.
- deleted 5y ago[deleted]